Cranberry Quercetin-3-Galactoside in Postprandial Human Plasma
Ajay P Singh2,3, Nicholi Vorsa2,3 and Ted Wilson1*
Affiliation
- 1Department of Biology, Winona State University, Winona, MN, USA
- 2Philip E. Marucci Center for Blueberry and Cranberry Research and Extension, Rutgers-The State University of New Jersey, 125A Lake Oswego Rd., Chatsworth, NJ, 08019, USA
- 3Department of Plant Biology and Pathology, Rutgers-The State University of New Jersey ,59 Dudley Road, New Brunswick, NJ, 08901, USA
Corresponding Author
Ted Wilson, Department of Biology, 232 Pasteur Hall, Winona State University, Winona, MN 55987; Phone: 507-457-2485; Fax: 507-457-2599; E-mail: twilson@winona.edu
Citation
Wilson, T. et al. Cranberry Quercetin-3-Galactoside in Postprandial Human Plasma (2014) Int J Food Nutr Sci 1(1): 17-19.
Copy rights
© 2014 Ted Wilson. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.
Abstract
Flavonoid glycoside bioavailability may be important for determining the health benefits of cranberry consumption. Human quercetin-3-galactoside bioavailability of raw cranberries (RC; 55g), sweetened dried cranberries(SDC; 40g) and sweetened dried cranberries containing less sugar (SDCLS; 40g) was measured using a liquid chromatography-mass spectrometry system before consumption and for 240 minutes postprandially. Peak plasma concentrations (ng/ml) for RV, SDC and SDCLS were 15.5 ± 3.0, 14.0 ± 2.9, and 9.8 ± 2.9, with observed peak times of 60, 60 and 120 minutes respectively. This study suggests that quercetin-3-galactoside in the blood stream could be used as a phenolic marker of cranberry consumption.
